Senior Director--Strategy at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Broad understanding of Lilly’s pipeline and portfolio strategy
Ability to capture trends in the external ecosystem and identify strategic and technical opportunities
Deep understanding of the biomedical innovation ecosystem in China/AP region
Strong understanding of the general strength of external parties and their potential to complement Lilly’s pipeline
Expertise in areas like ADMET, formulation, CMC, and emerging technologies (e.g., AIDD, automation)

Responsibilities

Lead the identification and rigorous assessment of potential in-licensing opportunities
Develop external competitive landscapes using multiple information sources and networking
Partner with Therapeutic Area (TA) S&E teams and co-lead/participate in partnering meetings and visits with external companies
Develop project concepts and execute projects when working with external groups
Communicate the results of technical evaluations to internal and external stakeholders
Develop relationships within the external pharmaceutical community in the A/P region (pharma, biotech, research institutes, academic organizations)
Develop key cross-discipline expertise in relevant areas

Skills

Key technologies and capabilities for this role

ADMETformulationCMCAIDDautomationportfolio strategycompetitive landscapebusiness developmentpartneringbiomedical innovationnetworking

Questions & Answers

Common questions about this position

Is this position remote?

Yes, the position is remote.

What is the salary for this Senior Director role?

This information is not specified in the job description.

What key skills are required for this role?

Required skills include a broad understanding of Lilly’s pipeline and portfolio strategy, deep knowledge of the biomedical innovation ecosystem in China and the Asia-Pacific region, ability to identify trends and opportunities, and expertise in areas like ADMET, formulation, CMC, and emerging technologies such as AIDD and automation.

What is the company culture like at Eli Lilly?

Eli Lilly is a global healthcare leader committed to uniting caring with discovery to make life better for people around the world, employing a diverse workforce dedicated to advancing healthcare solutions.

What makes a strong candidate for this Senior Director--Strategy position?

A strong candidate will have deep expertise in the China and Asia-Pacific biomedical innovation ecosystem, a solid grasp of Lilly’s pipeline, and technical knowledge in areas like ADMET, CMC, and emerging technologies, along with the ability to identify strategic opportunities and build external relationships.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free